Enabling continuous glucose monitoring (CGM) strategic roadmap for a global medical device innovator
Â
Quick Overview
| A global medical device innovator sought to analyze the future of continuous glucose monitoring (CGM) by identifying emerging technologies in sensing, body mounting, communication, and miniaturization. The goal was to guide R&D focus and strategic investments aligned with evolving patient and market needs. |    |
Client success details
FutureBridge supported the client with a comprehensive innovation landscape and strategic foresight. The engagement empowered decision-makers with clarity on future technology directions, startup activity, and high-priority white spaces.
The key questions addressed were:
 Â Â FutureBridge delivered a well-rounded view of the CGM innovation landscape. Their insights on early-stage players and emerging technologies helped us sharpen our foresight and align our R&D strategy with future market shifts. |
|
This structured foresight enabled the client to confidently shape a future-ready CGM roadmap, aligning innovation efforts with emerging technologies and unmet market needs.
Solution details
FutureBridge delivered a Strategic Foresight & Innovation Observatory focused on the future of Continuous Glucose Monitoring (CGM). The engagement provided:
-
A comprehensive market and technology landscape analysis of CGM systems, including innovations in sensors, sensing technologies, body mounting, communication, and miniaturization.
-
Insights on key innovations, competitors, early-stage players, and active R&D areas shaping the CGM segment.
-
A clear view of emerging opportunities and innovation directions to guide the client’s strategic focus and future planning.
FutureBridge impact
|
 |
________________________________________________________________________________
Leverage the potential of advanced Continuous Glucose Monitoring (CGM) —connect with our experts today to explore tailored strategies for your business.
